Dr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...
He has also criticized the FDA during campaign events, railing incorrectly about the agency's failure to approve a drug ...
Stephens initiates coverage on ADC Therapeutics (ADCT), highlighting Zynlonta's potential in second-line DLBCL and a ...
CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA ...
Almost every food brand has been affected by product recalls at some point, and Hostess is no different. These are some of ...
Asciminib has gained accelerated approval from the FDA for the treatment of patients with newly diagnosed Philadelphia ...
Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, the agency has done the same for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end of a d | ...
The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...
few patients with diabetes have been evaluated with the technology since it received FDA approval in 2021, a ...
CorMedix addresses catheter infections with its new solution, DefenCath. Read more about CRMD stock’s potential as the ...
The rate of emergency room visits for abortion complications appears to have increased since the FDA removed guardrails on ...